CLPBF (Coloplast AS) Cash Flow for Dividends: $-810 Mil (TTM As of Mar. 2026)


CLPBF Coloplast AS CLPBF
72 GF Score
Price $57.41
GF Value $126.91
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Coloplast AS Cash Flow for Dividends?

Coloplast AS CLPBF 72 Cash Flow for Dividends is $-810 Mil as of Mar. 2026. GuruFocus rates CLPBF with a GF Score™ of 72/100 and a GF Value™ of $126.91 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Coloplast AS's cash flow for dividends for the three months ended in Mar. 2026 was $0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was $-810 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Coloplast AS's quarterly payment of dividends increased from Sep. 2025 ($0 Mil) to Dec. 2025 ($-636 Mil) but then declined from Dec. 2025 ($-636 Mil) to Mar. 2026 ($0 Mil).

Coloplast AS's annual payment of dividends increased from Sep. 2023 ($-608 Mil) to Sep. 2024 ($-703 Mil) and increased from Sep. 2024 ($-703 Mil) to Sep. 2025 ($-780 Mil).

Coloplast AS Cash Flow for Dividends Related Terms

Coloplast AS Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Coloplast AS's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS Cash Flow for Dividends Chart

Coloplast AS Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -605.96 -537.58 -607.78 -702.59 -779.68

Coloplast AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -174.24 0.00 -636.05 0.00
CLPBF
72GF Score
Coloplast AS CLPBF
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coloplast AS Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-810 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of $-810 Mil mean?
Coloplast AS (CLPBF) has a Cash Flow for Dividends of $-810 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Coloplast AS and its competitors.
Is Coloplast AS's Cash Flow for Dividends too high?
Coloplast AS's current Cash Flow for Dividends is $-810 Mil. Overall, Coloplast AS has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's Cash Flow for Dividends compare to ISRG and BDX?
Coloplast AS's Cash Flow for Dividends of $-810 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Coloplast AS and its competitors. Coloplast AS's current Cash Flow for Dividends is $-810 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Based on GuruFocus' analysis, Coloplast AS (CLPBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $126.91, compared to a current price of $57.41 — trading 54.8% below its estimated fair value. The current Cash Flow for Dividends is $-810 Mil. Coloplast AS's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Coloplast AS (CLPBF), the current Cash Flow for Dividends is $-810 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Coloplast AS (CLPBF) Overvalued in 2026?

Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued. The current stock price of $57.41 is trading 54.8% below its estimated GF Value™ of $126.91. GuruFocus considers Coloplast AS to be Significantly Undervalued.

Key valuation signals for CLPBF:

  • Cash Flow for Dividends: $-810 Mil
  • GF Value™: $126.91 vs. price of $57.41 (54.8% below fair value)
  • GF Score™: 72/100 with 7 warning signs

No single metric tells the full story. See the CLPBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Coloplast AS Business Description

Address Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
72GF Score

Get the complete analysis for CLPBF

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$57.41
Price
$126.91
GF Value